Keyphrases
COVID-19
100%
Primary Antibody Deficiency
57%
Replacement Product
45%
Immunoglobulin Replacement
45%
Antibody Deficiency
44%
Neutralizing Activity
40%
Omicron Variant
33%
Antibody Response
32%
COVID-19 Vaccination
32%
Critical Care Needs
28%
IgG1
28%
Memory B-cell Response
28%
Optic Nerve Head Astrocytes
28%
Glioprotection
28%
Booster Vaccination
28%
Cell Viability Assay
28%
Plate Reader
28%
Hospitalization
28%
Inborn Errors of Immunity
28%
USIDNET
28%
MRNA Vaccine
28%
SARS-CoV-2 Infection
28%
Vaccination
24%
Tert-butyl Hydroperoxide (t-BHP)
22%
Immunoglobulin
19%
Anti-spike
17%
Oxidative Stress
14%
B Cell Response
12%
Primary Vaccination
12%
Optic Nerve Head
11%
Receptor-binding Domain
11%
Titer
11%
Antireceptor
11%
Protective Behavior
10%
Healthy Donors
10%
Immunoglobulin Prophylaxis
9%
Immune Deficiency
9%
XBB.1.5
9%
Glaucoma
8%
Maximal Effect
8%
Memory B Cells
8%
T Cell Response
8%
Healthy Individuals
8%
SARS-CoV-2 Vaccine
8%
ICU Admission
8%
COVID-19 Vaccine
8%
Optic Nerve
5%
Related Disorders
5%
Lactate Dehydrogenase Release
5%
Immunoglobulin Replacement Therapy (IgRT)
5%
Medicine and Dentistry
Humoral Immune Deficiency
32%
COVID-19 Vaccination
32%
COVID-19
32%
Primary Immunodeficiency
28%
Optic Nerve
28%
Cell Viability Assay
28%
Intensive Care
28%
Astrocyte
28%
Memory B Cell
28%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Immunoglobulin G1
28%
COVID-19 Vaccine
16%
Infection
16%
Tert Butyl Hydroperoxide
14%
B Cell
12%
T-Cell Response
12%
Messenger RNA
12%
Oxidative Stress
8%
Immune Response
8%
Immune Deficiency
8%
Glaucoma
5%
Trolox
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
85%
Humoral Immune Deficiency
57%
Intravenous Immunoglobulin
47%
Omicron Coronavirus Variant
35%
Antibody Response
32%
Memory B Cell
28%
Immunoglobulin G1
28%
Spike
17%
COVID-19
16%
Receptor Binding
14%
B Cell
12%
Titer
9%
Immune Response
8%
T Cell
8%
Antibody Titer
7%
Immunodeficiency
6%
